BioNano Genomics Inc vs Occidental Petroleum Corporation — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.66M), while Occidental Petroleum Corporation trades at $58.69 (market cap $55.89B). The key difference: Occidental Petroleum Corporation is far larger — about 4091.5× BioNano Genomics Inc's market cap, and Occidental Petroleum Corporation pays a 2% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | OXY | |
|---|---|---|
Market Cap | $13.66M | $55.89B |
Sector | Health | Energy |
52-Week High | $4.92 | $66.24 |
52-Week Low | $1.06 | $38.92 |
Enterprise Value | $16.26M | $74.65B |
Dividend Yield | — | 2% |
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
Occidental Petroleum (OXY) trades at $58.65, up 4.9% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $2.40, exceeding expectations, and is focusing on debt reduction while targeting over $4 billion in annual sustainable cash flow by 2030. Valuation ratios remain reasonable with a P/E of 16.49 and EV/EBITDA of 5.26.
The outlook is positive, driven by operational outperformance and higher oil prices, but remains sensitive to commodity volatility. Analyst consensus is a Buy with a $69.33 price target, though execution risks and oil price dependence are key considerations for investors.
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →